Part No: TN-SNAP-RPC-0211Issued year: 2011File size: 1.11mbFile type: pdf
Reversed-phase flash chromatography is a very popular
purification technique using a non-polar stationary phase.
Main application areas include separation of polar, ionizable
and highly lipophilic compounds which cannot easily be
separated by normal-phase techniques.
Part No: TN-0032.0112Issued year: 2012File size: 0.75mbFile type: pdf
Precision engineered Biotage SNAP Ultra cartridges deliver double
the purification capacity utilizing small particle spherical silica with
an 40% increase in surface area. This proprietary silica reduces
peak width and provides higher concentration fractions with less
Part No: PPS447Issued year: 2017File size: 0.96mbFile type: pdf
Biotage® SPE Dry 96 and SPE Dry 96 Dual Sample Concentrators are suitable for evaporation of microplate samples across a broad range of formats. By delivering heated gas above and below each well, SPE Dry 96 systems dry samples quickly maintaining tight temperature control at user selected settings. Designed for high throughput sample processing,
SPE Dry systems have simple front panel controls and use removable gas delivery assemblies for fast adjusting and cleaning.
Part No: PPS425Issued year: 2016File size: 2.58mbFile type: pdf
Biotage® V-10 Touch rapidly dries samples dissolved in both aqueous and organic solvents. Combined with the Gilson liquid handling robot automatically transfers your purified samples to V-10 Touch for sequential automated evaporation. This brochure lists all evaporation vials, adapters and accessories.
Part No: UI303Issued year: 2013File size: 4.69mbFile type: pdf
The Biotage® VacMaster™ is a state-of-the-art sample processing station. It incorporates innovative design features that make simultaneously processing multiple samples easier than ever before. For scientists working with biological fluids, these features and operating procedures provide a safe system.
Part No: UI327Issued year: 2015File size: 1.4mbFile type: pdf
Biotage® ACT Plate Adapter (patent pending) is designed to reduce or eliminate the occurrence of well-to-well cross contamination (cross talk) during extract evaporation, and fits on top of the 96-well collection plate during evaporation.
Part No: P137Issued year: 2015File size: 0.37mbFile type: pdf
This poster examines various factors in the development and optimisation of a SPE-LC-MS/MS method for extraction of catecholamines from plasma.
The final method utilizes EVOLUTE EXPRESS WCX plates in either standard SPE or fast Load-wash-elute modes, and incorporates a series of wash steps to optimise analytical sensitivity. Low elution volumes mean no evaporation step is required, and LLOQ is 20mg/mL or lower for each of the analytes.
Part No: P137v2Issued year: 2016File size: 0.39mbFile type: pdf
This poster investigates various parts of the SPE method development process to develop a highly sensitive LC-MS/MS method for analysis of catecholamines (epinephrine, norepinephrine, dopamine).
A number of steps are optimized to improve sensitivity of the
analytes. This includes reducing the buffer strength in the mobile
phase, reducing the buffer strength of washes, careful pH control
throughout the extraction, avoiding an evaporation step and
incorporating IPA in the reconstitution solvent.
Part No: Issued year: 2012File size: 0.11mbFile type: pdf
The following organization’s Quality Management System has been assessed and registered by Intertek Certification AB as conforming to the requirements of: SS-EN ISO 9001:2008
The Quality Management System is applicable to: Development and production of specialty polymers (MIPs and NIPs) for industrial separations and laboratory trace analysis.
Part No: CM-INT-0810Issued year: 2010File size: 0.25mbFile type: pdf
ChemMatrix is a patented, 100% PEG (polyethylene glycol)
based resin developed by PCAS BioMatrix that offers substantial
advantages over traditional PEG based polystyrene resins for
solid phase peptide synthesis.
Part No: RT-CM-0111Issued year: 2010File size: 0.09mbFile type: pdf
In order to keep your RapidTrace® workstation clean, in good working order and free from contamination it is of course essential to
routinely clean and purge the fluid path. Whichever matrix and reagents are running through the system, traces of these liquids will
be left after use; proteins from plasma, precipitates from buffers or even particulates from oral fluid. Over time if the following
cleaning schedule is not observed these contaminants could cause blockages leading to malfunctions and/or cross contamination.
Part No: P136Issued year: 2015File size: 0.6mbFile type: pdf
This poster compares the use of supported liquid extraction (ISOLUTE® SLE+) and a novel protein and phospholipid depletion plate (ISOLUTE® PLD+), for the extraction of 25-hydroxy vitamin D. The manual extraction protocols were transferred to an SPE automation platform (Biotage® Extrahera)and method performance versus manual processing compared.
MSACL EU 2015
Part No: PPS362Issued year: 2014File size: 1.23mbFile type: pdf
This product sheet compares automated sample preparation using the Biotage®Extrahera™ to an equivalent manual method utilizing a vacuum manifold. A selection of beta blocker drugs were extracted from pooled
stripped plasma using a supported liquid extraction procedure.
Part No: PPS366Issued year: 2014File size: 1.76mbFile type: pdf
Automated sample preparation using the Biotage®Extrahera™ was compared to an equivalent manual method utilizing a vacuum manifold. Analytes were extracted from pooled stripped plasma using a supported liquid extraction procedure.
Part No: PPS361Issued year: 2014File size: 1.28mbFile type: pdf
This document compares automated sample preparation using the Biotage®
Extrahera™ to an equivalent manual method utilizing a vacuum manifold. A selection of non-steroidal anti-inflammatory drugs (NSAIDS) were extracted from pooled stripped plasma using a supported liquid extraction procedure.
Part No: P142Issued year: 2016File size: 0.57mbFile type: pdf
This poster summarizes various sample preparation strategies for the
extraction of MMA from serum without the necessity for derivatization, prior to LC-MS/MS analysis. A range of sample preparation techniques of varying complexity were evaluated: protein precipitation, phospholipid depletion, supported liquid extraction and solid phase extraction using both silica and polymer-based mixed-mode anion exchange chemistries.
Method performance was evaluated for evaporative effects, assay recovery, ion suppression and phospholipid removal.
Part No: AN879Issued year: 2017File size: 0.89mbFile type: pdf
There are a wide range of volatile and semi-volatile contaminants finding their way into both terrestrial bodies and water sources worldwide. In the United States (US), the contaminants are analyzed
according to stipulated US-EPA methods. In the European Union (EU), a large number of these same compounds are tested according to the European Water Framework Directive. Though these analytes are approached differently from a regulatory perspective, it is clear that background monitoring occurs on a global basis. Initial extraction of these analytes depends on the matrix being analyzed and is often a multifaceted process, but ultimately analysts are presented with some form of extraction/organic solvent they must concentrate to achieve instrumental limits of quantification. Presented within this technical note are the results of such an evaporative process using the new Biotage TurboVap® II.
Part No: PPS430Issued year: 2016File size: 0.97mbFile type: pdf
At the Forensic Medicine Lab at Toho University, researchers use ISOLUTE® SLE+ columns from Biotage. When dealing with samples that easily form emulsions like urine or blood, it allows researchers to use the established liquid-liquid extraction technique, saving significant amount of time on analysis. We spoke with the Head of the Forensic Medicine Lab Professor Masaru Terada.
Part No: Issued year: 2009File size: 0.12mbFile type: pdf
Biotage AB was established in 1997 under the name Pyrosequencing AB and a number of acquisitions were performed within the Medicinal Chemistry sector during the years of 2003-2005. After divesting the business area Biosystems in October 2008, the Company’s business is today made up entirely of the business area Discovery Chemistry. Biotage’s headquarters is located in Uppsala.
Part No: Issued year: 2010File size: 0.2mbFile type: pdf
Biotage AB was established in 1997 under the name Pyrosequencing AB. The Company made a number of acquisitions in the medicinal chemistry sector between 2003 and 2005. Following the disposal of the Biosystems business area, the Company consists of one business area – Discovery Chemistry. The Company’s head office is situated in Uppsala. Biotage applies the Swedish Code of Corporate Governance (”the Swedish Code”). The diagram below shows Biotage’s corporate governance model and how the central bodies interact.
Part No: Issued year: 2011File size: 0.72mbFile type: pdf
Biotage AB was established in 1997 under the name Pyrosequencing AB. The Company made a number of acquisitions in the medicinal chemistry sector between 2003 and 2005. Following the disposal of the Biosystems business area, the Company consists of one business area – Discovery Chemistry. The Company’s head office is situated in Uppsala. Biotage applies the Swedish Code of Corporate Governance (“the Swedish Code”). The diagram below shows Biotage’s corporate governance model and how the central bodies interact.
Part No: Issued year: 2013File size: 0.11mbFile type: pdf
Biotage AB was established in 1997 under the name Pyrosequencing AB. The Company made a number of acquisitions in the medicinal chemistry sector between 2003 and 2005. Following the disposal of the Biosystems business area, the Company is mainly active within analytical and organic chemistry.